LUO Sheng;JIANG Da-lei;HUANG Ya-ling;HUANG Xiao-yu;QIN Hui-ying;WU Xing-juan;TAO Hang;YANG Jin;Center for Disease Prevention and Control of Wuming District,Nanning City;Objective To investigate the immunogenicity and safety of two-dose and booster immunization schedules of domestic live attenuated varicella vaccine(VarV). Methods From July 2015 to December 2017,300 healthy children at ages of 1 ~ 12 years,without vaccination history of VarV,were enrolled in two-dose immunization group,while 300 healthy children at ages of 4 ~ 13 years,who had been vaccinated with one dose of VarV,were enrolled in booster immunization group(immunization intervals were 1 ~ 3 and 4 ~ 6 years respectively),in six vaccination centers in Wuming District,Nanning City,Guangxi Zhuang Autonomous Region,China. The 1 st dose and the 2 nd dose of VarV were vaccinated on days 0 and 90 ~ 104 respectively. However,the children in the booster immunization group were boosted with one dose of VarV on day 0 after enrollment. Venous blood samples were collected from the children in two-dose immunization group before and 6 weeks after vaccination of the 1 st dose as well as 6 weeks after the 2 nd dose,and from those in booster immunization group before and 6 weeks after the booster immunization. Membrane antigen fluorescent antibody assay was used to detect the varicella zoster virus(VZV)antibody titer in sera. The immunization success rate,antibody geometric mean titer(GMT) and increasing fold of GMT in two groups were compared,while the systemic and local adverse reactions were observed within 42 d after vaccination. Results A total of 887 doses of VarV were vaccinated to 600 children,with a vaccination rate of 98. 56%. A total of 578 children were included into immunogenicity evaluation,while 887 doses into safety evaluation. The immunization success rate of the 2 nd dose in two-dose immunization group was 98. 93%,which was significantly higher than that of the 1 st dose(86. 83%)(P < 0. 001). However,in booster immunization group,the immunization success rate of children who were boosted 1 ~ 3 years(93. 96%)showed no significant difference with that 4 ~ 6 years(88. 51%)after the 1 st dose(P > 0. 05). Both the GMTs after the 1 st and the 2 nd doses in two-dose immunization group were significantly higher than those before vaccination(P < 0. 001),which increased by 9. 33 and 25. 12 folds respectively,while the GMT after the 2 nd dose was significantly higher than that after the 1 st dose(P < 0. 001). However,in booster immunization group,both the GMTs of children who were boosted at various time intervals after the 1 st dose were significantly higher than those before booster immunization(each P < 0. 001),which increased by 7. 93 and 7. 01 folds respectively,while the GMT of children boosted 1 ~ 3 years was significantly higher than that 4 ~ 6 years after the 1 st dose(P < 0. 05). The adverse reactions after vaccination with VarV were mainly fever,while no local adverse reactions were observed. The adverse reaction rates in booster immuni-zation group and two-dose immunization group were 2. 67% and 2. 89% respectively,which showed no significant diffe-rence(P > 0. 05). Conclusion Domestic VarV has great immunogenicity and safety in both two-dose and booster immunization schedules,which is suitable for popularization in the target children.
2019 12 v.32 [Abstract][OnlineView][Download 182K]